Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis - guidance (DG36)

National Institute for Health and Care Excellence - NICE
Publication date:
10 July 2019


Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Is this guidance up to date?

Next review: 2022

Guidance development process

How we develop NICE diagnostics guidance

This guidance replaces the NICE medtech innovation briefing on promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126).